Skeletal muscle IP3R1 receptors amplify physiological and pathological synaptic calcium signals

Journal of Neuroscience

Volumn 31, Issue 43, 2011, Pages 15269-15283

  Zhu, Haipeng ^a   Bhattacharyya, Bula J ^b   Lin, Hong ^c   Gomez, Christopher M ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CALPAIN; CHOLINERGIC RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; 2 AMINOETHOXYDIPHENYLBORANE; 2-AMINOETHOXYDIPHENYL BORATE; BORON DERIVATIVE; CALCIUM; CARBACHOL; CASPASE 3; CASPASE 9; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; GREEN FLUORESCENT PROTEIN; H2AX PROTEIN, MOUSE; HDAC5 PROTEIN, MOUSE; HISTONE; HISTONE DEACETYLASE; NEOSTIGMINE; NERVE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DNA DAMAGE; EXCITOTOXICITY; GENE EXPRESSION; GENE SILENCING; MALE; MOUSE; MUSCLE DENERVATION; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; SYNAPTIC TRANSMISSION; TIBIALIS ANTERIOR MUSCLE; ACTION POTENTIAL; ANIMAL; CELL LINE; CELL MEMBRANE POTENTIAL; CLASSIFICATION; CONGENITAL MYASTHENIC SYNDROME; DISEASE MODEL; DRUG EFFECT; ELECTROMYOGRAPHY; ELECTROPORATION; EXERCISE TEST; GENE EXPRESSION REGULATION; GENETICS; IN VITRO STUDY; METABOLISM; METHODOLOGY; PATCH CLAMP; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SCIATIC NERVE; TIME; TOXICITY AND INTOXICATION; TRANSGENIC MOUSE;

ACTION POTENTIALS; ANIMALS; BORON COMPOUNDS; CALCIUM; CALCIUM SIGNALING; CALPAIN; CARBACHOL; CASPASE 3; CASPASE 9; CELL LINE, TRANSFORMED; CHOLINERGIC AGONISTS; CHOLINESTERASE INHIBITORS; DISEASE MODELS, ANIMAL; ELECTROMYOGRAPHY; ELECTROPORATION; EXERCISE TEST; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HISTONE DEACETYLASES; HISTONES; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MALE; MEMBRANE POTENTIALS; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; MYASTHENIC SYNDROMES, CONGENITAL; NEOSTIGMINE; NERVE TISSUE PROTEINS; NEUROMUSCULAR JUNCTION; NEUROTOXICITY SYNDROMES; PATCH-CLAMP TECHNIQUES; RECEPTORS, CHOLINERGIC; RNA, SMALL INTERFERING; SCIATIC NERVE; TIME FACTORS;

EID: 80054956017     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3766-11.2011     Document Type: Article

References (91)

1. Acharya JK, Jalink K, Hardy RW, Hartenstein V, Zuker CS (1997) InsP3 receptor is essential for growth and differentiation but not for vision in Drosophila. Neuron 18:881-887.
2. Akaaboune M, Culican SM, Turney SG, Lichtman JW (1999) Rapid and reversible effects of activity on acetylcholine receptor density at the neuromuscular junction in vivo. Science 286:503-507.
3. Ariens AT, Cohen EM, Meeter E, Wolthuis OL (1968) Reversible necrosis in striated muscle fibres of the rat after severe intoxication with various cholinesterase inhibitors. IMS Ind Med Surg 37:845-847.
4. Backs J, Song K, Bezprozvannaya S, Chang S, Olson EN (2006) CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J Clin Invest 116:1853-1864.
5. Belmokhtar CA, Hillion J, Ségal-Bendirdjian E (2001) Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms. Oncogene 20:3354-3362.
6. Berridge MJ, Irvine RF (1984) Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 312:315-321.
7. Bezprozvanny I (2011) Role of inositol 1,4,5-trisphosphate receptors in pathogenesis of Huntington's disease and spinocerebellar ataxias. Neurochem Res 36:1186-1197.
8. Bhattacharyya BJ, Day JW, Gundeck JE, Leonard S, Wollmann RL, Gomez CM (1997) Desensitization of mutant acetylcholine receptors in transgenic mice reduces the amplitude of neuromuscular synaptic currents. Synapse 27:367-377.
9. Boehning D, Patterson RL, Sedaghat L, Glebova NO, Kurosaki T, Snyder SH (2003) Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis. Nat Cell Biol 5:1051-1061.
10. 2+ release. FASEB J 16:1145-1150.
11. Carlson CG, Kriebel ME (1985) Neostigmine increases the size of subunits composing the quantum of transmitter release at mouse neuromuscular junction. J Physiol 367:489-502.
12. Castelló A, Cadefau J, Cussó R, Testar X, Hesketh JE, Palacín M, Zorzano A (1993) GLUT-4 and GLUT-1 glucose transporter expression is differentially regulated by contractile activity in skeletal muscle. J Biol Chem 268:14998-15003.
13. Chen F, Qian L, Yang ZH, Huang Y, Ngo ST, Ruan NJ, Wang J, Schneider C, Noakes PG, Ding YQ, Mei L, Luo ZG (2007) Rapsyn interaction with calpain stabilizes AChR clusters at the neuromuscular junction. Neuron 55:247-260.
14. Choi DW (1992) Excitotoxic cell death. J Neurobiol 23:1261-1276.
15. Choi DW (1995) Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci 18:58-60.
16. Cohen TJ, Waddell DS, Barrientos T, Lu Z, Feng G, Cox GA, Bodine SC, Yao TP (2007) The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming. J Biol Chem 282:33752-33759.
17. Corna S, Galante M, Grasso M, Nardone A, Schieppati M (1996) Unilateral displacement of lower limb evokes bilateralEMGresponses in leg and foot muscles in standing humans. Exp Brain Res 109:83-91.
18. Decker ER, Dani JA (1990) Calcium permeability of the nicotinic acetylcholine receptor: the single-channel calcium influx is significant. J Neurosci 10:3413-3420.
19. Demuro A, Parker I, Stutzmann GE (2010) Calcium signaling and amyloid toxicity in Alzheimer disease. J Biol Chem 285:12463-12468.
20. Domet MA, Webb CE, Wilson DF (1995) Impact of alpha-bungarotoxin on transmitter release at the neuromuscular junction of the rat. Neurosci Lett 199:49-52.
21. Engel AG, Lambert EH, Gomez MR (1977) A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release. Ann Neurol 1:315-330.
22. Engel AG, Ohno K, Milone M, Wang HL, Nakano S, Bouzat C, Pruitt JN 2nd, Hutchinson DO, Brengman JM, Bren N, Sieb JP, Sine SM (1996) New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet 5:1217-1227.
23. Engel AG, Ohno K, Milone M, Sine SM (1998) Congenital myasthenic syndromes. New insights from molecular genetic and patch-clamp studies. Ann N Y Acad Sci 841:140-156.
24. Engel AG, Shen XM, Selcen D, Sine SM (2010) What have we learned from the congenital myasthenic syndromes. J Mol Neurosci 40:143-153.
25. 2+ channel function is linked to dystrophin expression inmammalian muscle. PLoS One 3:e1762.
26. 2+ overloading. J Physiol 573:35-43.
27. Furlan I, Godinho RO (2005) Developing skeletal muscle cells express functional muscarinic acetylcholine receptors coupled to different intracellular signaling systems. Br J Pharmacol 146:389-396.
28. Furuichi T, Shiota C, Mikoshiba K (1990) Distribution of inositol 1,4,5- trisphosphate receptor mRNA in mouse tissues. FEBS Lett 267:85-88.
29. Galeotti N, Bartolini A, Ghelardini C (2006) Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test. Neuropharmacology 50:309-316.
30. Gallego R, Kuno M, Núñez R, Snider WD (1979) Disuse enhances synaptic efficacy in spinal mononeurones. J Physiol 291:191-205.
31. Garcia N, Santafé MM, Salon I, Lanuza MA, Tomàs J (2005) Expression of muscarinic acetylcholine receptors (M1-, M2-, M3- and M4-type) in the neuromuscular junction of the newborn and adult rat. Histol Histopathol 20:733-743.
32. 2+ mobilization in mouse C2C12 myotubes. Cell Calcium 18:41-50.
33. Goldman D, Brenner HR, Heinemann S (1988) Acetylcholine receptor alpha-, beta-, gamma-, and delta-subunit mRNA levels are regulated by muscle activity. Neuron 1:329-333.
34. Golzio M, Mazzolini L, Moller P, Rols MP, Teissié J (2005) Inhibition of gene expression in mice muscle by in vivo electrically mediated siRNA delivery. Gene Ther 12:246-251.
35. Gomez CM, Maselli R, Gundeck JE, Chao M, Day JW, Tamamizu S, Lasalde JA, McNamee M, Wollmann RL (1997) Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction. J Neurosci 17:4170-4179.
36. Gomez CM, Maselli R, Williams JM, Bhattacharyya BB, Wollmann RL, Day JW (1998) Genetic manipulation of AChR responses suggests multiple causes of weakness in slow-channel syndrome. Ann N Y Acad Sci 841:167-180.
37. Gomez CM, Maselli RA, Groshong J, Zayas R, Wollmann RL, Cens T, Charnet P (2002) Active calcium accumulation underlies severe weakness in a panel of mice with slow-channel syndrome. J Neurosci 22:6447-6457.
38. Gómez-Sintes R, Lucas JJ (2010) NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy. J Clin Invest 120:2432-2445.
39. Groshong JS, Spencer MJ, Bhattacharyya BJ, Kudryashova E, Vohra BP, Zayas R, Wollmann RL, Miller RJ, Gomez CM (2007) Calpain activation impairs neuromuscular transmission in a mouse model of the slow-channel myasthenic syndrome. J Clin Invest 117:2903-2912.
40. Hampton TG, Stasko MR, Kale A, Amende I, Costa AC (2004) Gait dynamics in trisomic mice: quantitative neurological traits of Down syndrome. Physiol Behav 82:381-389.
41. Holland RL, Brown MC (1980) Postsynaptic transmission block can cause terminal sprouting of a motor nerve. Science 207:649-651.
42. Ikeda SR, Aronstam RS, Daly JW, Aracava Y, Albuquerque EX (1984) Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies. Mol Pharmacol 26:293-303.
43. Inoue T, Kato K, Kohda K, Mikoshiba K (1998) Type 1 inositol 1,4,5- trisphosphate receptor is required for induction of long-term depression in cerebellar Purkinje neurons. J Neurosci 18:5366-5373.
44. Itoh S, Ito K, Fujii S, Kaneko K, Kato K, Mikoshiba K, Kato H (2001) Neuronal plasticity in hippocampal mossy fiber-CA3 synapses of mice lacking the inositol-1,4,5-trisphosphate type 1 receptor. Brain Res 901:237-246.
45. Jones JP, Tapscott EB, Olson AL, Pessin JE, Dohm GL (1998) Regulation of glucose transporters GLUT-4 and GLUT-1 gene transcription in denervated skeletal muscle. J Appl Physiol 84:1661-1666.
46. Kashiwa HK, House CM Jr (1964) The glyoxal bis(2-hydroxyanil) method modified for localizing insoluble calcium salts. Stain Technol 39:359-367.
47. Kawabuchi M (1982) Neostigmine myopathy is a calcium ion-mediated myopathy initially affecting the motor end-plate. J Neuropathol Exp Neurol 41:298-314.
48. Kobayashi S, Yano M, Suetomi T, Ono M, Tateishi H, Mochizuki M, Xu X, Uchinoumi H, Okuda S, Yamamoto T, Koseki N, Kyushiki H, Ikemoto N, Matsuzaki M (2009) Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor. J Am Coll Cardiol 53:1993-2005.
49. Koelle GB, Friedenwald JA (1949) A histochemical method for localizing cholinesterase activity. Proc Soc Exp Biol Med 70:617-622.
50. Konishi Y, Kobayashi Y, Kishimoto T, Makino Y, Miyawaki A, Furuichi T, Okano H, Mikoshiba K, Tamura T (1997) Demonstration of an E-box and its CNS-related binding factors for transcriptional regulation of the mouse type 1 inositol 1,4,5-trisphosphate receptor gene. J Neurochem 69:476-484.
51. Laskowski MB, Dettbarn WD (1979) An electrophysiological analysis of the effects of paraoxon at the neuromuscular junction. J Pharmacol Exp Ther 210:269-274.
52. Lebrasseur NK, Coté GM, Miller TA, Fielding RA, Sawyer DB (2003) Regulation of neuregulin/ErbB signaling by contractile activity in skeletal muscle. Am J Physiol Cell Physiol 284:C1149-C1155.
53. Lee SG, Su ZZ, Emdad L, Sarkar D, Franke TF, Fisher PB (2008) Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene 27:1114-1121.
54. Leonard JP, Salpeter MM (1979) Agonist-induced myopathy at the neuromuscular junction is mediated by calcium. J Cell Biol 82:811-819.
55. Lømo T, Massoulié J, Vigny M (1985) Stimulation of denervated rat soleus muscle with fast and slow activity patterns induces different expression of acetylcholinesterase molecular forms. J Neurosci 5:1180-1187.
56. Marks AR (1997) Intracellular calcium-release channels: regulators of cell life and death. Am J Physiol 272:H597-H605.
57. Martinou JC, Merlie JP (1991) Nerve-dependent modulation of acetylcholine receptor epsilon-subunit gene expression. J Neurosci 11:1291-1299.
58. Matsumoto M, Nakagawa T, Inoue T, Nagata E, Tanaka K, Takano H, Minowa O, Kuno J, Sakakibara S, Yamada M, Yoneshima H, Miyawaki A, Fukuuchi Y, Furuichi T, Okano H, Mikoshiba K, Noda T (1996) Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature 379:168-171.
59. Megeath LJ, Fallon JR (1998) Intracellular calcium regulates agrin-induced acetylcholine receptor clustering. J Neurosci 18:672-678.
60. Méjat A, Ravel-Chapuis A, Vandromme M, Schaeffer L (2003) Synapsespecific gene expression at the neuromuscular junction. AnnN Y Acad Sci 998:53-65.
61. Miledi R, Parker I, Schalow G (1980) Transmitter induced calcium entry across the postsynaptic membrane at frog end-plates measured using arsenazo III. J Physiol 300:197-212.
62. Mondin L, Balghi H, Constantin B, Cognard C, Sebille S (2009) Negative modulation of inositol 1,4,5-trisphosphate type 1 receptor expression prevents dystrophin-deficient muscle cells death. Am J Physiol Cell Physiol 297:C1133-C1145.
63. Monnier N, Romero NB, Lerale J, Nivoche Y, Qi D, MacLennan DH, Fardeau M, Lunardi J (2000) An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor. Hum Mol Genet 9:2599-2608.
64. Moore C, Leu M, Müller U, Brenner HR (2001) Induction of multiple signaling loops by MuSK during neuromuscular synapse formation. Proc Natl Acad Sci U S A 98:14655-14660.
65. Mulder KJ, Mulder JB (1979) Ketamine and xylazine anesthesia in the mouse. Vet Med Small Anim Clin 74:569-570.
66. Murthy VN, Schikorski T, Stevens CF, Zhu Y (2001) Inactivity produces increases in neurotransmitter release and synapse size. Neuron 32:673-682.
67. Plomp JJ, van Kempen GT, Molenaar PC (1992) Adaptation of quantal content to decreased postsynaptic sensitivity at single endplates in alphabungarotoxin- treated rats. J Physiol 458:487-499.
68. 2+ signals localize to satellite cells and to components of the neuromuscular junction in skeletal muscle. J Neurosci 23:8185-8192.
69. Rogakou EP, Nieves-Neira W, Boon C, Pommier Y, Bonner WM (2000) Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J Biol Chem 275:9390-9395.
70. Ross CA, Danoff SK, Schell MJ, Snyder SH, Ullrich A (1992) Three additional inositol 1,4,5-trisphosphate receptors: molecular cloning and differential localization in brain and peripheral tissues. Proc Natl Acad Sci U S A 89:4265-4269.
71. Schertzer JD, Plant DR, Lynch GS (2006) Optimizing plasmid-based gene transfer for investigating skeletal muscle structure and function. Mol Ther 13:795-803.
72. Schieppati M, Nardone A, Siliotto R, Grasso M (1995) Early and late stretch responses of human foot muscles induced by perturbation of stance. Exp Brain Res 105:411-422.
73. 2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature 306:67-69.
74. Sugiyama JE, Glass DJ, Yancopoulos GD, Hall ZW (1997) Laminin-induced acetylcholine receptor clustering: an alternative pathway. J Cell Biol 139:181-191.
75. Sunesen M, Changeux JP (2003) Transcription in neuromuscular junction formation: who turns on whom? J Neurocytol 32:677-684.
76. Tang H, Macpherson P, Argetsinger LS, Cieslak D, Suhr ST, Carter-Su C, Goldman D (2004) CaM kinase II-dependent phosphorylation of myogenin contributes to activity-dependent suppression of nAChR gene expression in developing rat myotubes. Cell Signal 16:551-563.
77. Thiermann H, Zilker T, Eyer F, Felgenhauer N, Eyer P, Worek F (2009) Monitoring of neuromuscular transmission in organophosphate pesticidepoisoned patients. Toxicol Lett 191:297-304.
78. Tsay HJ, Schmidt J (1989) Skeletal muscle denervation activates acetylcholine receptor genes. J Cell Biol 108:1523-1526.
79. Villarroel A, Sakmann B (1996) Calcium permeability increase of endplate channels in rat muscle during postnatal development. J Physiol 496:331-338.
80. Vohra BP, Groshong JS, Maselli RA, Verity MA, Wollmann RL, Gomez CM (2004) Focal caspase activation underlies the endplate myopathy in slowchannel syndrome. Ann Neurol 55:347-352.
81. Vohra BP, Groshong JS, Zayas R, Wollmann RL, Gomez CM (2006) Activation of apoptotic pathways at muscle fiber synapses is circumscribed and reversible in a slow-channel syndrome model. Neurobiol Dis 23:462-470.
82. Wang X, Li Y, Engisch KL, Nakanishi ST, Dodson SE, Miller GW, Cope TC, Pinter MJ, Rich MM (2005) Activity-dependent presynaptic regulation of quantal size at the mammalian neuromuscular junction in vivo. J Neurosci 25:343-351.
83. 2+ dependence of the binomial parameters p and n at the mouse neuromuscular junction. J Neurophysiol 103:659-666.
84. Wells DJ (2004) Gene therapy progress and prospects: electroporation and other physical methods. Gene Ther 11:1363-1369.
85. Weston CA, Teressa G, Weeks BS, Prives J (2007) Agrin and laminin induce acetylcholine receptor clustering by convergent, Rho GTPase-dependent signaling pathways. J Cell Sci 120:868-875.
86. Wilson SM, Bhattacharyya B, Rachel RA, Coppola V, Tessarollo L, Householder DB, Fletcher CF, Miller RJ, Copeland NG, Jenkins NA (2002) Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease. Nat Genet 32:420-425.
87. Wright MC, Potluri S, Wang X, Dentcheva E, Gautam D, Tessler A, Wess J, Rich MM, Son YJ (2009) Distinct muscarinic acetylcholine receptor subtypes contribute to stability and growth, but not compensatory plasticity, of neuromuscular synapses. J Neurosci 29:14942-14955.
88. Yafe A, Shklover J, Weisman-Shomer P, Bengal E, Fry M (2008) Differential binding of quadruplex structures of muscle-specific genes regulatory sequences by MyoD, MRF4 and myogenin. Nucleic Acids Res 36:3916-3925.
89. Yang JS, Sladky JT, Kallen RG, Barchi RL (1991) TTX-sensitive and TTXinsensitive sodium channel mRNA transcripts are independently regulated in adult skeletal muscle after denervation. Neuron 7:421-427.
90. 2+ overload in slow-channel syndrome. Cell Calcium 41:343-352.
91. Zhu DL, Peng HB (1988) Increase in intracellular calcium induced by the polycation-coated latex bead, a stimulus that causes postsynaptictype differentiation in cultured Xenopus muscle cells. Dev Biol 126: 63-70.